Page 48 - IMR ANNUAL REPORT 2021: INSTITUTE FOR MEDICAL RESEARCH

IMR ANNUAL REPORT 2021 35

Bioassay Unit’s officer
performing in vitro anti-
SARS-CoV-2 testing at
the Biosafety Level 3
(BSL-3) facility

Bioassay Unit’s officer performing in vitro anti-SARS-CoV-2 testing at the Biosafety Level 3 (BSL-3) facility
Bioassay Unit’s officer performing in vitro anti-SARS-CoV-2 testing at the Biosafety Level 3 (BSL-3) facility
Laboratory Diagnostics/Services
HERBAL MEDICINE
Laboratory Diagnostics/Service
Laboratory Diagnostics/Services s
RESEARCH CENTRE (HMRC)
The Toxicology and Pharmacology Unit receives samples for testing of heavy
metals from MOH hospitals and private laboratories in the Klang Valley. The unit
The Toxicology and Pharmacology Unit receives samples for testing of heavy metals from MOH
The Toxicology and Pharmacology Unit receives samples for testing of heavy metals from MOH
also provides histopathological and analytical analyses for samples from Good
hospitals and private laboratories in the Klang Valley. The unit provides histopathological and
hospitals and private laboratories in the Klang Valley. The unit provides histopathological and
Laboratory Practices (GLP) preclinical studies, biochemical testing for animal
analytical analyses for samples from Good Laboratory Practices (GLP) preclinical studies,
analytical analyses for samples from Good Laboratory Practices (GLP) preclinical studies,
studies at IMR and urine/serum biochemical analyses from other studies. The
unit participates in the Trace Element External Quality Assessment Scheme
biochemical testing for animal studies at IMR and urine/serum biochemical analyses from other r
biochemical testing for animal studies at IMR and urine/serum biochemical analyses from othe
(RCPAQAP) in monitoring the analytical proficiency for urine copper testing.
studies. The unit participates in the Trace Element External Quality Assessment Scheme
studies. The unit participates in the Trace Element External Quality Assessment Scheme
(RCPAQAP) in monitoring the analytical proficiency for urine copper testing.
(RCPAQAP) in monitoring the analytical proficiency for urine copper testing.

Tests performed by the Toxicology & Pharmacology Unit
Tests performed by the Toxicology & Pharmacology Uni
Tests performed by the Toxicology & Pharmacology Unit t
Year
Year
Heavy Metal Test Year
2020
Heavy Metal Tes
Heavy Metal Test t 2021
2021
2020
Urine Copper 902 2020 2021 1230
Serum Copper 568 312
1230
Urine Coppe
902
Blood Lead Urine Copper r 902 1230 9
8
1478
Total Serum Copper r 568 312 1551
312
568
Serum Coppe
The GLP Section provides GLP compliant services based on requests from
Blood Lead
Blood Lead
9 9
8 8
sponsors for their products to be tested in terms of oral general toxicology in
Sprague Dawley or Wistar rats. Studies conducted follow the Organisation for
1478
1478
1551
Total
1551
Total
Economic Co-operation and Development (OECD) Test Guideline (TG) as in the
following table.

The GLP Section provides GLP compliant services based on requests from sponsors for thei
The GLP Section provides GLP compliant services based on requests from sponsors for their r
products to be tested in terms of oral general toxicology in Sprague Dawley or Wistar rats. Studies
products to be tested in terms of oral general toxicology in Sprague Dawley or Wistar rats. Studies
conducted follow the Organisation for Economic Co-operation and Development (OECD) Test
conducted follow the Organisation for Economic Co-operation and Development (OECD) Test
Guideline (TG) as in the following table.
Guideline (TG) as in the following table.

49 49